Market Overview

UPDATE: Canaccord Genuity Initiates Coverage on Sunshine Heart with Buy Rating, $11 PT

Related SSH
Morning Market Movers
Morning Market Movers

In a report published Friday, Canaccord Genuity initiated coverage on Sunshine Heart (NASDAQ: SSH) with a Buy rating and an $11.00 price target.

Canaccord noted, “We initiate coverage of Sunshine Heart (SSH) with a BUY rating and 12-month price target of $11.00/share. SSH offers investors the opportunity to participate in a nascent growth company that is commercializing potentially disruptive technology for the treatment of Class III heart failure. The company's minimally invasive C-Pulse Assist System demonstrated solid results in its US feasibility trial, namely solid safety data, including no stroke or thrombus-related events. We recommend investors accumulate shares of SSH common ahead of important potential catalysts.”

Sunshine Heart closed on Thursday at $6.85.

Latest Ratings for SSH

DateFirmActionFromTo
Feb 2014BTIG ResearchInitiates Coverage onNeutral
Oct 2013BenchmarkInitiates Coverage onSpeculative Buy
Jul 2013OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for SSH
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Initiation Analyst Ratings

 

Related Articles (SSH)

Around the Web, We're Loving...

Get Benzinga's Newsletters